Antibacterial, anti-chlamydial, and cytotoxic activities of a marine snail (Hexaplex trunculus) phospholipase A2: an in vitro study.

Appl Biochem Biotechnol

Laboratoire de biochimie et de génie enzymatique des lipases, Université de Sfax-Tunisie, ENIS route de Soukra, BPW, 1173 Sfax, Tunisia.

Published: October 2012

In order to report pharmacological characterization of marine snail (Hexaplex trunculus) hepatopancreatic phospholipase A(2) (mSDPLA(2)), we have talked for the first time the antimicrobial activity against different pathogenic bacterial strains, anti-chlamydial activity as well as its cytotoxic activity against McCoy cell lines. mSDPLA(2), showed a high level of activity towards Gram-positive bacteria as Staphylococcus aureus and Staphylococcus epidermidis. Whereas Gram-negative bacteria, unfortunately, exhibited a higher resistance, mSDPLA(2) was also found to have a strong cytotoxic activity, causing significant morphological alterations of the McCoy cell lines surfaces and to be a hinder to the proliferation. Moreover, mSDPLA(2) proved to have a very potent anti-chlamydial activity. Over 95 % inhibition of chlamydial inclusions were obtained at a concentration of 10 μg/ml of mSDPLA(2) after 24 h postinfection. Interestingly, at a concentration of 10 μg/ml of mSDPLA(2), the proliferation of McCoy cells was not affected. Approximately 50 % inhibition of cell growth was obtained with a concentration of 37 μg/mL of mSDPLA(2). mSDPLA(2) could be considered as an excellent candidate for the development of a new anti-infective agent. This enzyme showed significant antimicrobial activities.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12010-012-9826-1DOI Listing

Publication Analysis

Top Keywords

concentration μg/ml
12
μg/ml msdpla2
12
marine snail
8
snail hexaplex
8
hexaplex trunculus
8
msdpla2
8
anti-chlamydial activity
8
cytotoxic activity
8
mccoy cell
8
cell lines
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!